<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01429532</url>
  </required_header>
  <id_info>
    <org_study_id>CCPMOH2010-China2</org_study_id>
    <nct_id>NCT01429532</nct_id>
  </id_info>
  <brief_title>Outcomes of 3 Incision-size-dependent Phacoemulsification Systems</brief_title>
  <official_title>Clinical Evaluation of Three Incision-size-dependent Phacoemulsification Systems</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Natural Science Foundation of China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the outcomes of cataract surgery performed with three
      incision-size-dependent phacoemulsification systems (1.8, 2.2 and 3.0 mm).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is generally the case that smaller corneal cataract surgical incisions are associated with
      more rapid wound healing, more stable corneal biomechanical properties and less surgically
      induced astigmatism (SIA). With the development of phacoemulsification and foldable
      intraocular lenses (IOL) during recent decades, the size of clear corneal incisions has been
      reduced from 3.2-mm (coaxial small incision) to 1.4-mm (bimanual micro incision). Micro
      incision cataract surgery (MICS), including bimanual and micro coaxial phacoemulsification,
      has attracted much interest recently, due to its safety and ease of learning. However, the
      superiority of coaxial micro incision cataract surgery as compared conventional coaxial
      cataract surgery is still not certain, because micro incision phacoemulsification may result
      in longer ultrasound time (UST), the use of more ultrasonic power and consequently higher
      endothelial cell loss (ECL).

      In our previous studies of the OZil Torsional phacoemulsification system (Infinity, Alcon),
      we reported that the safety and effectiveness of cataract surgery are influenced by many
      factors, including the blade used to create the incision, the phacoemulsification apparatus,
      and the IOL and mode of IOL delivery, which together constitute a surgical system, whose
      outcomes are restricted by the best performance of each component. Today, micro coaxial
      phacoemulsification is in wide use for cataract surgery, but the lower limits of incision
      size should be understood in the context of the various components of the surgical system.

      In this study, we compared the safety and efficacy of three different incision-size-dependent
      phacoemulsification systems, 1.8, 2.2 and 3.0 mm, and evaluated the relationship between
      incision size and SIA.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2010</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Central Cornea Endothelial Cell Loss</measure>
    <time_frame>post-operative week 1, post-operative month 1, and post-operative month 3</time_frame>
    <description>Central cornea endothelial cell loss was calculated on the basis of preoperative and postoperative endothelial cell density.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Surgically Induced Astigmatism</measure>
    <time_frame>post-operative week 1, post-operative month 1, and post-operative month 3</time_frame>
    <description>Corneal astigmatism was measured using an eye scanner (Pentacam; Oculus, Wetzlar, Germany), and the SIA was calculated at each postoperative visit using the following equation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Best-corrected Visual Acuity</measure>
    <time_frame>post-operative week 1, post-operative month 1, and post-operative month 3</time_frame>
    <description>The best-corrected visual acuity (BCVA) was measured, using an ETDRS chart and auto-refraction as refined by an ophthalmologist, preoperatively and at postoperative 1 day, 1 week, 1 month and 3 months.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">120</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Group I</arm_group_label>
    <description>1.8-mm-incision-size phacoemulsification system</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group II</arm_group_label>
    <description>2.2-mm-incision-size phacoemulsification system</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group III</arm_group_label>
    <description>3.0-mm-incision-size phacoemulsification system</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>phacoemulsification</intervention_name>
    <description>Cataract surgery performed with three incision-size-dependent phacoemulsification systems (1.8, 2.2 and 3.0 mm)</description>
    <arm_group_label>Group I</arm_group_label>
    <arm_group_label>Group II</arm_group_label>
    <arm_group_label>Group III</arm_group_label>
    <other_name>Three incision-size(1.8, 2.2 and 3.0 mm)</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This prospective randomized study comprised 120 patients (120 eyes) with age-related
        cataract enrolled for surgeries between July 2010 and January 2011 at the Zhongshan
        Ophthalmic Center, Guangzhou, China.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age between 55 and 85 years

          -  the presence of nuclear or cortex-nuclear cataract, grades 2.0 to 4.0 (Lens Opacities
             Classification System III)

          -  a transparent central cornea

          -  pupil dilating to &gt;= 7 mm at the time of preoperative examination

          -  a preoperative central endothelial cell count of &gt;= 1500 cells per square millimeter

        Exclusion Criteria:

          -  previous intraocular surgery

          -  glaucoma

          -  pseudoexfoliation

          -  uveitis

          -  high myopia

          -  diabetes mellitus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yizhi Liu, M.D.,Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>Sun Yat-sen University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Zhongshan Ophthalmic Center, Sun Yat-sen U</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510060</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://www.gzzoc.com</url>
    <description>Home page of our investigation ophthalmic center</description>
  </link>
  <reference>
    <citation>Weikert MP. Update on bimanual microincisional cataract surgery. Curr Opin Ophthalmol. 2006 Feb;17(1):62-7. Review.</citation>
    <PMID>16436926</PMID>
  </reference>
  <reference>
    <citation>Alió JL, Agdeppa MC, Rodríguez-Prats JL, Amparo F, Piñero DP. Factors influencing corneal biomechanical changes after microincision cataract surgery and standard coaxial phacoemulsification. J Cataract Refract Surg. 2010 Jun;36(6):890-7. doi: 10.1016/j.jcrs.2009.12.041.</citation>
    <PMID>20494758</PMID>
  </reference>
  <reference>
    <citation>Elkady B, Piñero D, Alió JL. Corneal incision quality: microincision cataract surgery versus microcoaxial phacoemulsification. J Cataract Refract Surg. 2009 Mar;35(3):466-74. doi: 10.1016/j.jcrs.2008.11.047.</citation>
    <PMID>19251139</PMID>
  </reference>
  <results_reference>
    <citation>Liu Y, Jiang Y, Wu M, Liu Y, Zhang T. Bimanual microincision phacoemulsification in treating hard cataracts using different power modes. Clin Exp Ophthalmol. 2008 Jul;36(5):426-30.</citation>
    <PMID>18939349</PMID>
  </results_reference>
  <results_reference>
    <citation>Liu Y, Zeng M, Liu X, Luo L, Yuan Z, Xia Y, Zeng Y. Torsional mode versus conventional ultrasound mode phacoemulsification: randomized comparative clinical study. J Cataract Refract Surg. 2007 Feb;33(2):287-92.</citation>
    <PMID>17276271</PMID>
  </results_reference>
  <results_reference>
    <citation>Zeng M, Liu X, Liu Y, Xia Y, Luo L, Yuan Z, Zeng Y, Liu Y. Torsional ultrasound modality for hard nucleus phacoemulsification cataract extraction. Br J Ophthalmol. 2008 Aug;92(8):1092-6. doi: 10.1136/bjo.2007.128504. Epub 2008 Jun 20.</citation>
    <PMID>18567650</PMID>
  </results_reference>
  <results_reference>
    <citation>Wang Y, Xia Y, Zeng M, Liu X, Luo L, Chen B, Liu Y, Liu Y. Torsional ultrasound efficiency under different vacuum levels in different degrees of nuclear cataract. J Cataract Refract Surg. 2009 Nov;35(11):1941-5. doi: 10.1016/j.jcrs.2009.05.055.</citation>
    <PMID>19878827</PMID>
  </results_reference>
  <results_reference>
    <citation>Xia Y, Liu X, Luo L, Zeng Y, Cai X, Zeng M, Liu Y. Early changes in clear cornea incision after phacoemulsification: an anterior segment optical coherence tomography study. Acta Ophthalmol. 2009 Nov;87(7):764-8. doi: 10.1111/j.1755-3768.2008.01333.x. Epub 2009 Jun 22.</citation>
    <PMID>19548882</PMID>
  </results_reference>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 4, 2011</study_first_submitted>
  <study_first_submitted_qc>September 6, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 7, 2011</study_first_posted>
  <results_first_submitted>December 25, 2012</results_first_submitted>
  <results_first_submitted_qc>June 6, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 11, 2014</results_first_posted>
  <last_update_submitted>June 6, 2014</last_update_submitted>
  <last_update_submitted_qc>June 6, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 11, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Haotian Lin</investigator_full_name>
    <investigator_title>Department of cataract, Zhongshan Ophthalmic Center</investigator_title>
  </responsible_party>
  <keyword>Cataract</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>This prospective randomized study included 120 patients (120 eyes) with age-related cataract enrolled between July 2010 and January 2011 at the Zhong-shan Ophthalmic Center, Guangzhou, China.</recruitment_details>
      <pre_assignment_details>Potential subjects with previous intraocular surgery, glaucoma, pseudoexfoliation, uveitis, high myopia and diabetes mellitus were excluded from participation in the study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Group I</title>
          <description>1.8-mm-incision-size phacoemulsification system</description>
        </group>
        <group group_id="P2">
          <title>Group II</title>
          <description>2.2-mm-incision-size phacoemulsification system</description>
        </group>
        <group group_id="P3">
          <title>Group III</title>
          <description>3.0-mm-incision-size phacoemulsification system</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="40"/>
                <participants group_id="P3" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="40"/>
                <participants group_id="P3" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Group I</title>
          <description>1.8-mm-incision-size phacoemulsification system</description>
        </group>
        <group group_id="B2">
          <title>Group II</title>
          <description>2.2-mm-incision-size phacoemulsification system</description>
        </group>
        <group group_id="B3">
          <title>Group III</title>
          <description>3.0-mm-incision-size phacoemulsification system</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="40"/>
            <count group_id="B2" value="40"/>
            <count group_id="B3" value="40"/>
            <count group_id="B4" value="120"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="28"/>
                    <measurement group_id="B4" value="84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="73.95" spread="6.05"/>
                    <measurement group_id="B2" value="71.37" spread="7.19"/>
                    <measurement group_id="B3" value="72.48" spread="6.15"/>
                    <measurement group_id="B4" value="72.59" spread="6.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="21"/>
                    <measurement group_id="B4" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="19"/>
                    <measurement group_id="B4" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>China</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="40"/>
                    <measurement group_id="B4" value="120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Central Cornea Endothelial Cell Loss</title>
        <description>Central cornea endothelial cell loss was calculated on the basis of preoperative and postoperative endothelial cell density.</description>
        <time_frame>post-operative week 1, post-operative month 1, and post-operative month 3</time_frame>
        <population>The SPSS software package (version 17.0, SPSS Inc, Chicago, IL, USA) was used for statistical analysis and sample size calculation. Mean ultrasound time (UST), surgical time, cumulative dissipated energy (CDE), total BSS volume, and SIA were compared using multifactor analysis of variance.</population>
        <group_list>
          <group group_id="O1">
            <title>Group I</title>
            <description>1.8-mm-incision-size phacoemulsification system</description>
          </group>
          <group group_id="O2">
            <title>Group II</title>
            <description>2.2-mm-incision-size phacoemulsification system</description>
          </group>
          <group group_id="O3">
            <title>Group III</title>
            <description>3.0-mm-incision-size phacoemulsification system</description>
          </group>
        </group_list>
        <measure>
          <title>Central Cornea Endothelial Cell Loss</title>
          <description>Central cornea endothelial cell loss was calculated on the basis of preoperative and postoperative endothelial cell density.</description>
          <population>The SPSS software package (version 17.0, SPSS Inc, Chicago, IL, USA) was used for statistical analysis and sample size calculation. Mean ultrasound time (UST), surgical time, cumulative dissipated energy (CDE), total BSS volume, and SIA were compared using multifactor analysis of variance.</population>
          <units>% of endothelial cell loss</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Post-op 1m</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.78" spread="7.27"/>
                    <measurement group_id="O2" value="13.03" spread="8.33"/>
                    <measurement group_id="O3" value="12.05" spread="9.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-op 1 w</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.77" spread="3.76"/>
                    <measurement group_id="O2" value="9.35" spread="4.69"/>
                    <measurement group_id="O3" value="7.93" spread="3.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-op 3 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.83" spread="5.65"/>
                    <measurement group_id="O2" value="18.08" spread="7.93"/>
                    <measurement group_id="O3" value="17.66" spread="5.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Best-corrected Visual Acuity</title>
        <description>The best-corrected visual acuity (BCVA) was measured, using an ETDRS chart and auto-refraction as refined by an ophthalmologist, preoperatively and at postoperative 1 day, 1 week, 1 month and 3 months.</description>
        <time_frame>post-operative week 1, post-operative month 1, and post-operative month 3</time_frame>
        <population>The SPSS software package (version 17.0, SPSS Inc, Chicago, IL, USA) was used for statistical analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Group I</title>
            <description>1.8-mm-incision-size phacoemulsification system</description>
          </group>
          <group group_id="O2">
            <title>Group II</title>
            <description>2.2-mm-incision-size phacoemulsification system</description>
          </group>
          <group group_id="O3">
            <title>Group III</title>
            <description>3.0-mm-incision-size phacoemulsification system</description>
          </group>
        </group_list>
        <measure>
          <title>Best-corrected Visual Acuity</title>
          <description>The best-corrected visual acuity (BCVA) was measured, using an ETDRS chart and auto-refraction as refined by an ophthalmologist, preoperatively and at postoperative 1 day, 1 week, 1 month and 3 months.</description>
          <population>The SPSS software package (version 17.0, SPSS Inc, Chicago, IL, USA) was used for statistical analysis.</population>
          <units>logMAR</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-op 1 day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.16" spread="0.10"/>
                    <measurement group_id="O2" value="0.13" spread="0.11"/>
                    <measurement group_id="O3" value="0.15" spread="0.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-op 1 day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.66" spread="0.27"/>
                    <measurement group_id="O2" value="0.71" spread="0.20"/>
                    <measurement group_id="O3" value="0.73" spread="0.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-op 1 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.89" spread="0.20"/>
                    <measurement group_id="O2" value="0.91" spread="0.13"/>
                    <measurement group_id="O3" value="0.88" spread="0.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-op 3 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.98" spread="0.11"/>
                    <measurement group_id="O2" value="1.01" spread="0.09"/>
                    <measurement group_id="O3" value="0.98" spread="0.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Surgically Induced Astigmatism</title>
        <description>Corneal astigmatism was measured using an eye scanner (Pentacam; Oculus, Wetzlar, Germany), and the SIA was calculated at each postoperative visit using the following equation.</description>
        <time_frame>post-operative week 1, post-operative month 1, and post-operative month 3</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group I</title>
            <description>1.8-mm-incision-size phacoemulsification system</description>
          </group>
          <group group_id="O2">
            <title>Group II</title>
            <description>2.2-mm-incision-size phacoemulsification system</description>
          </group>
          <group group_id="O3">
            <title>Group III</title>
            <description>3.0-mm-incision-size phacoemulsification system</description>
          </group>
        </group_list>
        <measure>
          <title>Surgically Induced Astigmatism</title>
          <description>Corneal astigmatism was measured using an eye scanner (Pentacam; Oculus, Wetzlar, Germany), and the SIA was calculated at each postoperative visit using the following equation.</description>
          <units>Diopters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Post-op 1 day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="0.32"/>
                    <measurement group_id="O2" value="0.91" spread="0.34"/>
                    <measurement group_id="O3" value="0.951" spread="0.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-op 1 week</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.61" spread="0.24"/>
                    <measurement group_id="O2" value="0.74" spread="0.25"/>
                    <measurement group_id="O3" value="0.79" spread="0.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-op 1 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" spread="0.21"/>
                    <measurement group_id="O2" value="0.46" spread="0.24"/>
                    <measurement group_id="O3" value="0.75" spread="0.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-op 3 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.26" spread="0.18"/>
                    <measurement group_id="O2" value="0.31" spread="0.19"/>
                    <measurement group_id="O3" value="0.66" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>Total Number of Participants at Risk for this Observational Study (e.g., serious and/or other [non-serious] adverse events were not collected/assessed).</desc>
      <group_list>
        <group group_id="E1">
          <title>Group I</title>
          <description>1.8-mm-incision-size phacoemulsification system</description>
        </group>
        <group group_id="E2">
          <title>Group II</title>
          <description>2.2-mm-incision-size phacoemulsification system</description>
        </group>
        <group group_id="E3">
          <title>Group III</title>
          <description>3.0-mm-incision-size phacoemulsification system</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Prof. Yizhi Liu</name_or_title>
      <organization>SunYat-senU</organization>
      <phone>+86-20-87330341</phone>
      <email>Reviewborad_SYsU@163.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

